Progressive abdominal pain with acute exacerbation due to retroperitoneal follicular dendritic cell sarcoma: a case report with targeted genomic sequencing analysis

References

• Jain P, Milgrom SA, Patel KP, et al. Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma. Br J Haematol. 2017;178(3):403–412.
   PubMed Web of Science ®Google Scholar
• Facchetti F, Simbeni M, Lorenzi L. Follicular dendritic cell sarcoma. Pathologica. 2021;113(5):316–329.
   PubMed Web of Science ®Google Scholar
• Wu A, Pullarkat S. Follicular dendritic cell sarcoma. Arch Pathol Lab Med. 2016;140(2):186–190.
   PubMed Web of Science ®Google Scholar
• Nagy A, Bhaduri A, Shahmarvand N, et al. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. Blood Adv. 2018;2(5):481–491.
   PubMed Web of Science ®Google Scholar
• Yoon SS. The new American joint commission on cancer staging system for soft tissue sarcomas: splitting versus lumping. Ann Surg Oncol. 2018;25(5):1101–1102.
   PubMed Web of Science ®Google Scholar
• Chen T, Gopal P. Follicular dendritic cell sarcoma. Arch Pathol Lab Med. 2017;141(4):596–599.
   PubMed Web of Science ®Google Scholar
• Chen HM, Shen YL, Liu M. Primary hepatic follicular dendritic cell sarcoma: a case report. World J Clin Cases. 2019;7(6):785–791.
   PubMed Web of Science ®Google Scholar
• Yuan T, Yang Q, Zhang H, et al. A 46-year-old Chinese woman presenting with retroperitoneal follicular dendritic cell sarcoma: a case report. J Med Case Rep. 2014;8:113.
   PubMedGoogle Scholar
• Li Z, Jin K, Yu X, et al. Extranodal follicular dendritic cell sarcoma in mesentery: a case report. Oncol Lett. 2011;2(4):649–652.
   PubMed Web of Science ®Google Scholar
• Lu T, Song B, Pu H, et al. Paraneoplastic pemphigus and myasthenia gravis as the first manifestations of a rare case of pancreatic follicular dendritic cell sarcoma: CT findings and review of literature. BMC Gastroenterol. 2019;19(1):92.
   PubMedGoogle Scholar
• Soriano AO, Thompson MA, Admirand JH, et al. Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature. Am J Hematol. 2007;82(8):725–728.
   PubMed Web of Science ®Google Scholar
• Rakheja R, Makis W, Skamene S, et al. Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients. Am J Roentgenol. 2012;198(6):1409–1416.
   PubMed Web of Science ®Google Scholar
• Chan JK, Fletcher CD, Nayler SJ, et al. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer. 1997;79(2):294–313.
   PubMed Web of Science ®Google Scholar
• Saygin C, Uzunaslan D, Ozguroglu M, et al. Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series. Crit Rev Oncol Hematol. 2013;88(2):253–271.
   PubMed Web of Science ®Google Scholar
• Lee MY, Bernabe-Ramirez C, Ramirez DC, et al. Follicular dendritic cell sarcoma and its response to immune checkpoint inhibitors nivolumab and ipilimumab. BMJ Case Rep. 2020;13(4):e234363.
   PubMedGoogle Scholar
• Griffin GK, Weirather JL, Roemer MGM, et al. Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma. Blood. 2021;137(10):1353–1364.
   PubMed Web of Science ®Google Scholar
• Chalmers ZR, Connelly CF, Fabrizio D, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9(1):34.
   PubMed Web of Science ®Google Scholar
• Massoth LR, Hung YP, Ferry JA, et al. Histiocytic and dendritic cell sarcomas of hematopoietic origin share targetable genomic alterations distinct from follicular dendritic cell sarcoma. Oncologist. 2021;26(7):e1263–e1272.
   PubMed Web of Science ®Google Scholar
• London M, Gallo E. Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics. Mol Biol Rep. 2020;47(7):5523–5533.
   PubMed Web of Science ®Google Scholar
• Chiari R, Hames G, Stroobant V, et al. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules. Cancer Res. 2000;60(17):4855–4863.
   PubMed Web of Science ®Google Scholar
• Tu MM, Lee FYF, Jones RT, et al. Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy. Sci Adv. 2019;5(2):eaav2437.
   PubMed Web of Science ®Google Scholar
• Andersen EF, Paxton CN, O'Malley DP, et al. Genomic analysis of follicular dendritic cell sarcoma by molecular inversion probe array reveals tumor suppressor-driven biology. Mod Pathol. 2017;30(9):1321–1334.
   PubMed Web of Science ®Google Scholar
• Griffin GK, Sholl LM, Lindeman NI, et al. Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-kappaB regulatory genes. Mod Pathol. 2016;29(1):67–74.
   PubMed Web of Science ®Google Scholar